Sarah A. Morrow

5.6k total citations · 2 hit papers
140 papers, 3.5k citations indexed

About

Sarah A. Morrow is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Sarah A. Morrow has authored 140 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Pathology and Forensic Medicine, 38 papers in Neurology and 18 papers in Rheumatology. Recurrent topics in Sarah A. Morrow's work include Multiple Sclerosis Research Studies (105 papers), Peripheral Neuropathies and Disorders (22 papers) and Systemic Lupus Erythematosus Research (10 papers). Sarah A. Morrow is often cited by papers focused on Multiple Sclerosis Research Studies (105 papers), Peripheral Neuropathies and Disorders (22 papers) and Systemic Lupus Erythematosus Research (10 papers). Sarah A. Morrow collaborates with scholars based in Canada, United States and United Kingdom. Sarah A. Morrow's co-authors include Ralph H. B. Benedict, Bianca Weinstock‐Guttman, Robert Zivadinov, Heather Rosehart, Ruth Ann Marrie, John D. Fisk, Marcelo Kremenchutzky, James Marriott, Christina Wolfson and Marcus Koch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and JAMA.

In The Last Decade

Sarah A. Morrow

130 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incidence and prevalence of multiple sclerosis in Europe: a systematic review

2013 386 citations Elaine Kingwell, James Marriott et al. BMC Neurology profile →
Multiple sclerosis

2023 202 citations Robert Zivadinov, Sarah A. Morrow et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah A. Morrow Canada	30	2.4k	857	419	393	321	140	3.5k
Claudio Gobbi Switzerland	30	2.0k 0.9×	1.2k 1.4×	457 1.1×	417 1.1×	315 1.0×	158	3.7k
Chiara Zecca Switzerland	24	1.4k 0.6×	736 0.9×	332 0.8×	389 1.0×	222 0.7×	129	2.7k
Özgür Yaldizli Switzerland	31	1.7k 0.7×	901 1.1×	285 0.7×	267 0.7×	259 0.8×	73	2.7k
Bonnie I. Glanz United States	31	2.2k 0.9×	732 0.9×	566 1.4×	321 0.8×	249 0.8×	110	3.3k
Sharon Lynch United States	35	2.1k 0.9×	574 0.7×	266 0.6×	601 1.5×	257 0.8×	118	3.3k
Benedetta Goretti Italy	35	3.3k 1.4×	1.0k 1.2×	512 1.2×	372 0.9×	500 1.6×	58	3.8k
Jeannette Lechner‐Scott Australia	27	1.9k 0.8×	960 1.1×	399 1.0×	321 0.8×	216 0.7×	158	3.3k
Peter Flachenecker Germany	30	2.1k 0.9×	990 1.2×	255 0.6×	749 1.9×	274 0.9×	118	3.4k
Marino Zorzon Italy	34	1.9k 0.8×	758 0.9×	482 1.2×	662 1.7×	242 0.8×	68	3.1k
Yves Lapierre Canada	31	1.9k 0.8×	730 0.9×	370 0.9×	484 1.2×	278 0.9×	58	3.9k

Countries citing papers authored by Sarah A. Morrow

Since Specialization

Citations

This map shows the geographic impact of Sarah A. Morrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah A. Morrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah A. Morrow more than expected).

Fields of papers citing papers by Sarah A. Morrow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah A. Morrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah A. Morrow. The network helps show where Sarah A. Morrow may publish in the future.

Co-authorship network of co-authors of Sarah A. Morrow

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah A. Morrow. A scholar is included among the top collaborators of Sarah A. Morrow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah A. Morrow. Sarah A. Morrow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Leavitt, Victoria M., et al.. (2025). The language and memory test: A brief multidomain digital cognitive measure for multiple sclerosis. Multiple Sclerosis Journal. 31(11). 1348–1357.

König, Andrea, Rosane Nisenbaum, Mark S. Freedman, et al.. (2025). Comparison of vision-related quality of life in NMOSD and MOGAD. Multiple Sclerosis and Related Disorders. 97. 106392–106392.

Gomes, Cátia, Sailee S. Lavekar, Sarah A. Morrow, et al.. (2024). A highly reproducible and efficient method for retinal organoid differentiation from human pluripotent stem cells. Proceedings of the National Academy of Sciences. 121(25). e2317285121–e2317285121. 25 indexed citations

Morrow, Sarah A., Katherine Knox, Anthony Feinstein, et al.. (2024). Experiences of people with multiple sclerosis and clinicians in using cognitive behavioural therapies for hidden symptoms: a systematic review and meta-aggregation. Journal of Neurology. 271(3). 1084–1107. 5 indexed citations

Morrow, Sarah A., et al.. (2023). Establishing the consistency of a voice recognition symbol digit modalities test analogue. Multiple Sclerosis Journal. 29(13). 1676–1679. 2 indexed citations

Morrow, Sarah A., Omid Mirmosayyeb, Devon Conway, et al.. (2023). Detecting isolated cognitive relapses in persons with MS. Multiple Sclerosis Journal. 29(14). 1786–1794. 7 indexed citations

Bogaardt, Hans, Daniel Golan, Stacie Attrill, et al.. (2023). Cognitive impairment, fatigue and depression in multiple sclerosis: Is there a difference between benign and non-benign MS?. Multiple Sclerosis and Related Disorders. 73. 104630–104630. 10 indexed citations

Marrie, Ruth Ann, Virginia Devonshire, Draga Jichici, et al.. (2023). Good multiple sclerosis (MS) care and how to get there in Canada: Perspectives of Canadian healthcare providers working with persons with MS. Frontiers in Neurology. 14. 1101521–1101521. 5 indexed citations

Morrow, Sarah A., et al.. (2022). Importance of Identifying Cognitive Impairment in Multiple Sclerosis. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 50(6). 813–819. 3 indexed citations

10.

Morrow, Sarah A., et al.. (2022). Use of natalizumab in persons with multiple sclerosis: 2022 update. Multiple Sclerosis and Related Disorders. 65. 103995–103995. 41 indexed citations

11.

Morrow, Sarah A., Devon Conway, Tom Fuchs, et al.. (2021). Interpreting change on the Symbol Digit Modalities Test in people with relapsing multiple sclerosis using the reliable change methodology. Multiple Sclerosis Journal. 28(7). 1101–1111. 38 indexed citations

12.

Johnson, Andrew M., et al.. (2021). Predictors of cognitive fatigue and fatigability in multiple sclerosis. Multiple Sclerosis and Related Disorders. 56. 103316–103316. 10 indexed citations

13.

Blair, Mervin, et al.. (2021). Does cognitive training improve attention/working memory in persons with MS? A pilot study using the Cogmed Working Memory Training program. Multiple Sclerosis and Related Disorders. 49. 102770–102770. 17 indexed citations

14.

Hawkins, R A, Anwar S. Shatil, L. Lee, et al.. (2020). Reduced Global Efficiency and Random Network Features in Patients with Relapsing-Remitting Multiple Sclerosis with Cognitive Impairment. American Journal of Neuroradiology. 41(3). 449–455. 12 indexed citations

15.

Maranzano, Josefina, Mahsa Dadar, David A. Rudko, et al.. (2019). Comparison of Multiple Sclerosis Cortical Lesion Types Detected by Multicontrast 3T and 7T MRI. American Journal of Neuroradiology. 40(7). 1162–1169. 32 indexed citations

16.

Classen, Sherrilene, et al.. (2019). Clinical Determinants of Fitness to Drive in Persons With Multiple Sclerosis: Systematic Review. Archives of Physical Medicine and Rehabilitation. 100(8). 1534–1555. 10 indexed citations

17.

Blair, Mervin, et al.. (2019). Predictors of vocational status among persons with multiple sclerosis. Multiple Sclerosis and Related Disorders. 36. 101411–101411. 17 indexed citations

18.

Kingwell, Elaine, James Marriott, Nathalie Jetté, et al.. (2013). Incidence and prevalence of multiple sclerosis in Europe: a systematic review. BMC Neurology. 13(1). 128–128. 386 indexed citations breakdown →

19.

Morrow, Sarah A., Audrey Smerbeck, Kara Patrick, et al.. (2012). Lisdexamfetamine dimesylate improves processing speed and memory in cognitively impaired MS patients: a phase II study. Journal of Neurology. 260(2). 489–497. 33 indexed citations

20.

Morrow, Sarah A., Allison Drake, Robert Zivadinov, et al.. (2010). Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline. The Clinical Neuropsychologist. 24(7). 1131–1145. 205 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact